3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
420
Precursor Cell Lymphoblastic Leukemia-Lymphoma
126
Neoplasms, Plasma Cell
74
Recurrence
70
Lymphoma
57
Leukemia
54
Neoplasms
46
Immunoglobulin Light-chain Amyloidosis
38
Burkitt Lymphoma
37
Vomiting
36
Lymphoma, Mantle-Cell
32
Lymphoma, Large B-Cell, Diffuse
31
Nausea
29
Lymphoma, Non-Hodgkin
28
Breast Neoplasms
22
Waldenstrom Macroglobulinemia
21
Lymphoma, Follicular
21
Hodgkin Disease
21
Leukemia, Lymphocytic, Chronic, B-Cell
20
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Neoplasm Metastasis
17
Prostatic Neoplasms
16
Lymphoma, Extranodal NK-T-Cell
16
Amyloidosis
16
Leukemia, Myeloid, Acute
15
Smoldering Multiple Myeloma
14
Lymphoma, B-Cell, Marginal Zone
13
Lung Neoplasms
11
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, B-Cell
10
Interventions
Educational Status
2
vedolizumab
1
Vitamin E
1
Vaccines
1
Sutures
1
Surveys and Questionnaires
1
Surgical Instruments
1
Standard of Care
1
Soybean Oil
1
Saline Solution
1
Ringer's Lactate
1
Proctocolectomy, Restorative
1
Practice Guidelines as Topic
1
Pneumococcal Vaccines
1
Photoplethysmography
1
Phlebotomy
1
Papillomavirus Vaccines
1
Nivolumab
1
Methods
1
Lysine Acetyltransferase 5
1
Laparoscopy
1
Iron-Dextran Complex
1
Interviews as Topic
1
Infliximab
1
Indigo Carmine
1
Hydroxyethyl Starch Derivatives
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Herpes Zoster Vaccine
1
Fish Oils
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Crohn Disease
×
Dexamethasone
×
Clear all
NCT05432934
2023-12-07
TAP-DEX
University of Saskatchewan
Phase 1/2
Unknown
60 enrolled